Search
for
Sort by
Research 721–750 of 735
- Anti‐Doping Testing at FIFA World Cup 2022
- Clinical characteristics and risk factors of female precocious puberty
- The study of pubertal stage and age of menarche in girls in Isfahan province, Iran
- Androgens and Hirsutism in a Large Cohort of Portuguese Women
- The Impact of Vitamin D Receptor Gene Polymorphisms (FokI, ApaI, TaqI) in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome
- Causal effects of omega‐6 and LDL‐C on androgenetic alopecia: A Mendelian randomization study
- The Need and Management of hormone Imbalances in Women
- Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Landing Eyes on Unnoticed Disorder: A Polycystic Ovary Syndrome
- The Transgender: Endocrinological Assessment
- Acne associated gynecological diseases and risk factors in the multiethnic women
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Medical Options for Care of Gender Diverse and Transgender Youth
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Ovarian hyperthecosis in adolescent females: two case reports and a review of the literature
- REAL WORLD STUDY ON ORAL ESTRADIOL TREATMENT IN TRANSGENDER WOMEN
- SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
- Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*